September 2024

26/09/2024
Blogs
No Comments
Eminence

Navigating PV Audits: Best Practices, Do’s and Don’ts for Success

Rajendra Kumar Kasi, Vice President and Global Head – Pharmacovigilance, Glenmark in conversation with Team Eminence Business MediaPharmacovigilance audits are vital to ensuring that pharmaceutical companies meet regulatory guidelines and, more importantly, protect patient safety. These audits ensure that companies follow rigorous protocols for detecting, assessing, and preventing adverse drug reactions. It was a pleasure…
Read More
19/09/2024
Blogs
No Comments
Eminence

September 2024 Nitrosamine Guidelines Update: What Indian Pharma Companies Need to Know Now

Guarding Against Nitrate Variability and Water Contamination: New Nitrosamine Guidelines Released In a move that’s shaking up the pharma industry, regulatory bodies worldwide have introduced stricter guidelines on nitrosamine impurities in medicinal products as of September 2024. Nitrosamines, known for their potential to increase cancer risks, can form during drug manufacturing or storage. With these…
Read More
09/09/2024
Blogs
No Comments
Eminence

Is AI the Future of Drug Safety? A Global Perspective on AI in Pharmacovigilance

Alina PanourgiaPharmacovigilance and Regulatory Compliance AdvisorComposite PharmaIs AI the ultimate answer to drug safety? As pharmacovigilance evolves to keep pace with the pharmaceutical industry, the rise of Artificial Intelligence is transforming how we monitor the safety of medicines. AI offers incredible potential by analysing vast amounts of safety data from health records, patient registries, and…
Read More